Supreme Court Blocks Purdue Pharma Bankruptcy Deal, Citing Concerns Over Sackler Family Accountability

In a significant legal development, the Supreme Court has rejected a contentious bankruptcy deal involving Purdue Pharma, the manufacturer of OxyContin. This decision has been lauded by Connecticut Attorney General William Tong, who described it as “a definitive rebuke of the Sackler family’s abuse of the bankruptcy code.” The outcome underscores ongoing concerns about the Sackler family’s attempts to evade accountability through manipulated financial structures. For more details, you can read the article here.